科研之友
微信
新浪微博
Facebook
分享链接
摘要
<正>1文献来源Robert NJ,Diéras V,Glaspy J,et al,RIBBON-1:Randomized,double-blind,placebo-controlled,phaseⅢtrial of chemotherapy with or without Bevacizumab for first-line treatment of human epidermal growth factor receptor2-negative,locally recurrent or metastatic breast cancer[J].J Clin Oncol,2011,29(10)...
- 出版日期2012
- 单位福建省肿瘤医院; 广东省人民医院
